Common Stock, Shares, Issued of Propanc Biopharma, Inc. from Q2 2011 to Q3 2025

Taxonomy & unit: us-gaap: shares
Description: Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary: Propanc Biopharma, Inc. quarterly Common Stock, Shares, Issued history and change rate from Q2 2011 to Q3 2025.
Propanc Biopharma, Inc. Common Stock, Shares, Issued for the quarter ending 30 Sep 2025 was 12.8M shares, a 98.1% decline year-over-year.

Common Stock, Shares, Issued, Quarterly (shares)

Common Stock, Shares, Issued, YoY Quarterly Change (%)

Propanc Biopharma, Inc. Quarterly Common Stock, Shares, Issued (shares)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	12.8M	-675M	-98.1%	30 Sep 2025	10-Q	14 Nov 2025
Q2 2025	11.6M	+11.6M		30 Jun 2025	10-Q	14 Nov 2025
Q1 2025	11.6M	-98.1M	-89.4%	31 Mar 2025	10-Q	15 May 2025
Q4 2024	14.5K^*	-36.2M		31 Dec 2024	10-Q	14 Feb 2025
Q3 2024	688M	+673M	+4538%	30 Sep 2024	10-Q	14 Nov 2024
Q2 2024	7.98K^*	-6.02M		30 Jun 2024	10-K	29 Sep 2025
Q1 2024	110M	-2.51B	-95.8%	31 Mar 2024	10-Q	15 May 2024
Q4 2023	36.2M	-1.21B	-97.1%	31 Dec 2023	10-Q	20 Feb 2024
Q3 2023	14.8M	-662M	-97.8%	30 Sep 2023	10-Q	14 Nov 2023
Q2 2023	6.03M	+5.81M	+2637%	30 Jun 2023	10-K	30 Sep 2024
Q1 2023	2.62B	+2.54B	+2983%	31 Mar 2023	10-Q	15 May 2023
Q4 2022	1.25B	+1.19B	+2248%	31 Dec 2022	10-Q	10 Feb 2023
Q3 2022	677M	+633M	+1445%	30 Sep 2022	10-Q	14 Nov 2022
Q2 2022	220K	-13.8M	-98.4%	30 Jun 2022	10-K	28 Sep 2023
Q1 2022	85M	+80.1M	+1611%	31 Mar 2022	10-Q	16 May 2022
Q4 2021	53.1M	+51.6M	+3567%	31 Dec 2021	10-Q	14 Feb 2022
Q3 2021	43.8M	-672M	-93.9%	30 Sep 2021	10-Q	12 Nov 2021
Q2 2021	14.1M	+13.8M	+5345%	30 Jun 2021	10-K	28 Sep 2022
Q1 2021	4.97M	-13.5M	-73.1%	31 Mar 2021	10-Q	14 May 2021
Q4 2020	1.45M	-788K	-35.3%	31 Dec 2020	10-Q	12 Feb 2021
Q3 2020	716M	+714M	+61063%	30 Sep 2020	10-Q	16 Nov 2020
Q2 2020	258K	-710K	-73.3%	30 Jun 2020	10-K	28 Sep 2021
Q1 2020	18.5M	-367M	-95.2%	31 Mar 2020	10-Q	15 May 2020
Q4 2019	2.23M	-271M	-99.2%	31 Dec 2019	10-Q	14 Feb 2020
Q3 2019	1.17M	-174M	-99.3%	30 Sep 2019	10-Q	14 Nov 2019
Q2 2019	968K	+875K		30 Jun 2019	10-K	01 Oct 2020
Q1 2019	385M	+354M	+1139%	31 Mar 2019	10-Q	15 May 2019
Q4 2018	273M	+256M	+1445%	31 Dec 2018	10-Q	14 Feb 2019
Q3 2018	176M	+169M	+2531%	30 Sep 2018	10-Q	13 Nov 2018
Q2 2018	92.9K^*	-4.49M		30 Jun 2018	10-K	15 Oct 2019
Q1 2018	31.1M	+27.3M	+730%	31 Mar 2018	10-Q	10 May 2018
Q4 2017	17.7M	-850M	-98%	31 Dec 2017	10-Q	09 Feb 2018
Q3 2017	6.67M	-787M	-99.2%	30 Sep 2017	10-Q	09 Nov 2017
Q2 2017	4.58M	+1.66M	+57.1%	30 Jun 2017	10-K	17 Sep 2018
Q1 2017	3.74M	-599M	-99.4%	31 Mar 2017	10-Q	08 May 2017
Q4 2016	867M	+435M	+100%	31 Dec 2016	10-Q	14 Feb 2017
Q3 2016	794M	+437M	+123%	30 Sep 2016	10-Q	10 Nov 2016
Q2 2016	2.91M	-345M	-99.2%	30 Jun 2016	10-K	28 Sep 2017
Q1 2016	602M	+270M	+81%	31 Mar 2016	10-Q	16 May 2016
Q4 2015	433M	+302M	+231%	31 Dec 2015	10-Q	16 Feb 2016
Q3 2015	357M	+274M	+331%	30 Sep 2015	10-Q	16 Nov 2015
Q2 2015	347M	+275M	+378%	30 Jun 2015	10-K	28 Sep 2016
Q1 2015	333M	+260M	+358%	31 Mar 2015	10-Q	15 May 2015
Q4 2014	131M	+58.1M	+79.9%	31 Dec 2014	10-Q	17 Feb 2015
Q3 2014	82.8M	+11M	+15.3%	30 Sep 2014	10-Q	19 Nov 2014
Q2 2014	72.7M	+2.05M	+2.91%	30 Jun 2014	10-K	30 Sep 2015
Q1 2014	72.7M	+2.05M	+2.91%	31 Mar 2014	10-Q	20 May 2014
Q4 2013	72.7M	-136K	-0.19%	31 Dec 2013	10-Q	14 Feb 2014
Q3 2013	71.8M	-876K	-1.21%	30 Sep 2013	10-Q	14 Nov 2013
Q2 2013	70.6M	-2.07M	-2.85%	30 Jun 2013	10-K	14 Oct 2014
Q1 2013	70.6M	-1.52M	-2.11%	31 Mar 2013	10-Q	20 May 2013
Q4 2012	72.8M	+817K	+1.14%	31 Dec 2012	10-Q	20 Feb 2013
Q3 2012	72.7M			30 Sep 2012	10-Q	19 Nov 2012
Q2 2012	72.7M	+790K	+1.1%	30 Jun 2012	10-K	15 Oct 2013
Q1 2012	72.2M			31 Mar 2012	10-Q	21 May 2012
Q4 2011	72M			31 Dec 2011	10-Q/A	07 Mar 2012
Q2 2011	71.9M			30 Jun 2011	10-K	15 Oct 2012

* An asterisk sign (*) next to the value indicates that the value is likely invalid.